ANALYSIS — Revolution Medicines' Europe efforts signal solo launch ambitions for cancer drug
European Commission review to follow after EMA panel backing RevMed gears up hiring in Europe, LinkedIn postings show Analysts say company can pursue ex-US launch alone By Sriparna Roy and Bhanvi Satija Oct 15 (Reuters) — Revolution Medicines is laying the groundwork for a broad European commercial rollout of its pancr